NCT03746158View on ClinicalTrials.gov

Interindividual Variation in Excretion of Curcumin

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

October 1, 2019

Conditions
MetabolitesGut Microbiota
Interventions
DIETARY_SUPPLEMENT

curcumin

subjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).

Trial Locations (1)

01003

Institute for Applied Life Sciences, Amherst

All Listed Sponsors
lead

University of Massachusetts, Amherst

OTHER

NCT03746158 - Interindividual Variation in Excretion of Curcumin | Biotech Hunter | Biotech Hunter